Literature DB >> 11769247

Distribution of 14C cylindrospermopsin in vivo in the mouse.

R L Norris1, A A Seawright, G R Shaw, M J Smith, R K Chiswell, M R Moore.   

Abstract

Radiolabelled 14C cylindrospermopsin (CYN) has been prepared and used to investigate the distribution and excretion of CYN in vivo in male Quackenbush mice. At a dose of 0.2 mg/kg (i.e., approx. median lethal dose) the following mean (SD) urinary and faecal recoveries (cumulative) were obtained, respectively: (0-6 hours, n = 4) 48.2 (29.3)%, 11.9 (21.4)%; (0-12 hours, n = 12) 66.0 (27.1)%, 5.7 (5.6)%; (0-24 hours, n = 12) 68.4 (26.7)%, 8.5 (8.1)%. Mean (SD) recoveries from livers at 6 hours were 20.6 (6.4)% (n = 4), at 48 hours 13.1 (7.7)% (n = 8), and 5-7 days were 2.1 (2.1)% (n = 8). A substantial amount (up to 23%) can be retained in the liver for up to 48 hours with a lesser amount retained in the kidneys. The excretion patterns show substantial interindividual variability between predominantly faecal or urinary excretion, but these patterns are not related in any simple manner to the outcome in terms of toxicity. There is at least one methanol-extractable metabolite as well as a nonmethanol-extractable metabolite in the liver. The methanol-extractable metabolite was not found in the kidney and is more hydrophilic than CYN itself on reverse phase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11769247

Source DB:  PubMed          Journal:  Environ Toxicol        ISSN: 1520-4081            Impact factor:   4.119


  8 in total

1.  Toxicity and recovery in the pregnant mouse after gestational exposure to the cyanobacterial toxin, cylindrospermopsin.

Authors:  N Chernoff; E H Rogers; R D Zehr; M I Gage; D E Malarkey; C A Bradfield; Y Liu; J E Schmid; R H Jaskot; J H Richards; C R Wood; M B Rosen
Journal:  J Appl Toxicol       Date:  2010-10-08       Impact factor: 3.446

Review 2.  Cylindrospermopsin: a decade of progress on bioaccumulation research.

Authors:  Susan Kinnear
Journal:  Mar Drugs       Date:  2010-03-09       Impact factor: 5.118

3.  Immunohistochemical approach to study cylindrospermopsin distribution in tilapia (Oreochromis niloticus) under different exposure conditions.

Authors:  Remedios Guzmán-Guillén; Daniel Gutiérrez-Praena; María de los Ángeles Risalde; Rosario Moyano; Ana Isabel Prieto; Silvia Pichardo; Ángeles Jos; Vitor Vasconcelos; Ana María Cameán
Journal:  Toxins (Basel)       Date:  2014-01-08       Impact factor: 4.546

4.  Influence of two depuration periods on the activity and transcription of antioxidant enzymes in tilapia exposed to repeated doses of cylindrospermopsin under laboratory conditions.

Authors:  Victoria Ríos; Remedios Guzmán-Guillén; Isabel M Moreno; Ana I Prieto; María Puerto; Angeles Jos; Ana M Cameán
Journal:  Toxins (Basel)       Date:  2014-03-13       Impact factor: 4.546

Review 5.  In Vitro Toxicological Assessment of Cylindrospermopsin: A Review.

Authors:  Silvia Pichardo; Ana M Cameán; Angeles Jos
Journal:  Toxins (Basel)       Date:  2017-12-16       Impact factor: 4.546

6.  Inhibition of growth rate and cylindrospermopsin synthesis by Raphidiopsis raciborskii upon exposure to macrophyte Lemna trisulca (L).

Authors:  Kornelia Duchnik; Jan Bialczyk; Ewelina Chrapusta-Srebrny; Beata Bober
Journal:  Ecotoxicology       Date:  2021-03-12       Impact factor: 2.823

Review 7.  A review and assessment of cyanobacterial toxins as cardiovascular health hazards.

Authors:  Zorica Svirčev; Liang Chen; Kinga Sántha; Damjana Drobac Backović; Stamenko Šušak; Aleksandra Vulin; Tamara Palanački Malešević; Geoffrey A Codd; Jussi Meriluoto
Journal:  Arch Toxicol       Date:  2022-08-23       Impact factor: 6.168

Review 8.  Occupational and environmental hazard assessments for the isolation, purification and toxicity testing of cyanobacterial toxins.

Authors:  Ian Stewart; Wayne W Carmichael; Ross Sadler; Glenn B McGregor; Karen Reardon; Geoffrey K Eaglesham; Wasantha A Wickramasinghe; Alan A Seawright; Glen R Shaw
Journal:  Environ Health       Date:  2009-11-19       Impact factor: 5.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.